New hope for frail myeloma patients: shorter drug combos show promise

NCT ID NCT07107529

Recruiting now Disease control Sponsor: European Myeloma Network B.V. Source: ClinicalTrials.gov ↗

First seen Apr 30, 2026 · Last updated May 14, 2026 · Updated 4 times

Summary

This study tests two new drug combinations (teclistamab plus daratumumab or talquetamab plus daratumumab) given for a fixed time in 150 frail patients newly diagnosed with multiple myeloma. The goal is to see how long the cancer stays under control and how well patients tolerate the treatment. Participants must be 18 or older and have measurable disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ES-Barcelona-H.U. Vall d'Hebrón [06-002]
NOT_YET_RECRUITING

Barcelona, Spain
ES-Las Palmas-H.U. de Gran Canaria Dr Negrín [06-030]
NOT_YET_RECRUITING

Las Palmas, Spain
ES-Murcia-H.U. Virgen de la Arrixaca [06-016]
RECRUITING

Murcia, Spain
ES-Salamanca-H.U. de Salamanca [06-021]
NOT_YET_RECRUITING

Salamanca, Spain
IT-Ascoli Piceno-Ospedale Mazzoni [01-016]
RECRUITING

Ascoli Piceno, Italy
IT-Bari-A.O.U. Consorziale Policlinico - Medicina Interna [01-018]
NOT_YET_RECRUITING

Bari, Italy
IT-Bergamo-A.O. Papa Giovanni XXIII [01-003]
NOT_YET_RECRUITING

Bergamo, Italy
IT-Bologna-A.O.U. di Bologna - Policlinico S. Orsola Malpighi [01-004]
NOT_YET_RECRUITING

Bologna, Italy
IT-Bolzano-Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige [01-021]
NOT_YET_RECRUITING

Bolzano, Italy
IT-Como-Ospedale Classificato Valduce [01-104]
RECRUITING

Como, Italy
IT-Milano-Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico [01-039]
NOT_YET_RECRUITING

Milan, Italy
IT-Milano-Ospedale S. Carlo Borromeo [01-105]
RECRUITING

Milan, Italy
IT-Novara-A.O.U. Maggiore della Carità [01-010]
RECRUITING

Novara, Italy
IT-Pescara-Azienda USL di Pescara P.O. dello Spirito Santo [01-053]
RECRUITING

Pescara, Italy
IT-Roma-ASL Roma 1 [01-101]
NOT_YET_RECRUITING

Roma, Italy
IT-Roma-Policlinico Umberto I - Università 'Sapienza' [01-013]
NOT_YET_RECRUITING

Roma, Italy
IT-Torino-A.O.U. Città della Salute e della Scienza di Torino-SSD Clinical trials [01-001]
NOT_YET_RECRUITING

Torino, Italy
IT-Varese-Ospedale di Circolo [01-111]
NOT_YET_RECRUITING

Varese, Italy
NL-Amsterdam-Vrije Universiteit Medical Center (VUMC) [02-007]
NOT_YET_RECRUITING

Amsterdam, Netherlands
NL-Arnhem-Rijnstate Hospital [02-009]
NOT_YET_RECRUITING

Arnhem, Netherlands
NL-Den Haag-Haga Ziekenhuis [02-016]
NOT_YET_RECRUITING

The Hague, Netherlands
NL-Enschede-Medisch Spectrum Twente [02-024]
NOT_YET_RECRUITING

Enschede, Netherlands
NL-Groningen-University Medical Center Groningen [02-030]
NOT_YET_RECRUITING

Groningen, Netherlands
NL-Nieuwegein-S. Antonius Hospital [02-038]
NOT_YET_RECRUITING

Nieuwegein, Netherlands
NL-Schiedam-Franciscus Vlietland Hospital [02-049]
NOT_YET_RECRUITING

Schiedam, Netherlands
NL-Sittard-Geleen-Zuyderland Medical Center [02-058]
NOT_YET_RECRUITING

Sittard, Netherlands
NL-Zwolle-Isala Klinieken [02-057]
NOT_YET_RECRUITING

Zwolle, Netherlands
NO-Oslo-Oslo University Hospital [23-007]
NOT_YET_RECRUITING

Oslo, Norway
NO-Tønsberg-Vestfold Hospital Trust [23-012]
NOT_YET_RECRUITING

Tønsberg, Norway

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA (MM)